Erector Spinae Block Using a Dexmedetomidine Versus Magnesium Sulfate as an Adjuvant to Bupivacaine

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

January 20, 2023

Study Completion Date

February 1, 2023

Conditions
Postoperative Analgesia
Interventions
PROCEDURE

Erector spinae block using bupivacaine 0.25% and magnesium sulfate

"After induction of general anesthesia the patients will be flipped to the prone position and ESP block was performed using, a high frequency linear ultrasound probe placed longitudinally 2 to 3 cm lateral to the 10th thoracic vertebrae, and the trapezius and erector Spinae muscles identified.~An 18-G Tuohy needle passed along the plane of the transducer until its tip hit the transverse process of T10; the needle was then withdrawn slightly.~Total volume of 25 ml was injected including 20 mL 0.25% bupivacaine plus 3.75 ml NS and 125 mg MgSO4 (1.25ml)."

PROCEDURE

Erector spinae block using bupivacaine and dememdetomidine

"After induction of general anesthesia the patients will be flipped to the prone position and ESP block was performed using, a high frequency linear ultrasound probe placed longitudinally 2 to 3 cm lateral to the 10th thoracic vertebrae, and the trapezius and erector Spinae muscles identified.~An 18-G Tuohy needle passed along the plane of the transducer until its tip hit the transverse process of T10; the needle was then withdrawn slightly.~Total volume of 25 ml was injected including 20 mL 0.25% bupivacaine plus dexmedetomidine 1ug/kg."

Trial Locations (1)

11728

Ain Shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05694897 - Erector Spinae Block Using a Dexmedetomidine Versus Magnesium Sulfate as an Adjuvant to Bupivacaine | Biotech Hunter | Biotech Hunter